Association of the genetic variants of APOA5 and PRKCH with hypertension in community-dwelling Japanese individuals

Molecular Medicine Reports

Volumn 1, Issue 3, 2008, Pages 407-414

  Yamada, Yoshiji ^a   Ando, Fujiko ^b   Shimokata, Hiroshi ^b  

^a MIE UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

APOA5; Genetics; Hypertension; Polymorphism; PRKCH

Indexed keywords

APOLIPOPROTEIN A5; EOTAXIN; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE C;

AGED; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; COMMUNITY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; FLUORESCENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; JAPANESE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSPECTIVE STUDY; SEX DIFFERENCE; SITTING; SYSTOLIC BLOOD PRESSURE;

EID: 58849090796     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.1.3.407     Document Type: Article

References (32)

1. Lifton RP, Gharavi AG and Geller DS: Molecular mechanisms of human hypertension. Cell 104: 545-556, 2001.
2. Caulfield M, Munroe P, Pembroke J, et al: Genome-wide mapping of human loci for essential hypertension. Lancet 361: 2118-2123, 2003. (Pubitemid 36782256)
3. Gong M, Zhang H, Schulz H, et al: Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p. Hum Mol Genet 12: 1273-1277, 2003. (Pubitemid 36722607)
4. De Lange M, Spector TD and Andrew T: Genome-wide scan for blood pressure suggests linkage to chromosome 11, and replication of loci on 16, 17, and 22. Hypertension 44: 872-877, 2004. (Pubitemid 39577414)
5. Wallace C, Xue MZ, Newhouse SJ, et al: Linkage analysis using co-phenotypes in the BRIGHT study reveals novel potential susceptibility loci for hypertension. Am J Hum Genet 79: 323-331, 2006. (Pubitemid 44141830)
6. Cusi D, Barlassina C, Azzani T, et al: Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension. Lancet 349: 1353-1357, 1997. (Pubitemid 27197537)
7. Siffert W, Rosskopf D, Siffert G, et al: Association of a human G-protein β3 subunit variant with hypertension. Nat Genet 18: 45-48, 1998. (Pubitemid 28027877)
8. Izawa H, Yamada Y, Okada T, Tanaka M, Hirayama H and Yokota M: Prediction of genetic risk for hypertension. Hypertension 41: 1035-1040, 2003.
9. Yamada Y, Matsuo H, Segawa T, et al: Assessment of the genetic component of hypertension. Am J Hypertens 19: 1158-1165, 2006.
10. Shimokata H, Ando F and Niino N: A new comprehensive study on aging - the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). J Epidemiol 10: S1-S9, 2000.
11. Yamada Y, Ando F, Niino N and Shimokata H: Association of polymorphisms of androgen receptor and klotho genes with bone mineral density in Japanese women. J Mol Med 83: 50-57, 2005. (Pubitemid 40169496)
12. Yamada Y, Ando F and Shimokata H: Association of a microsomal triglyceride transfer protein gene polymorphism with blood pressure in Japanese women. Int J Mol Med 17: 83-88, 2006.
13. Yamada Y, Ando F and Shimokata H: Association of gene polymorphisms with blood pressure and the prevalence of hypertension in community-dwelling Japanese individuals. Int J Mol Med 19: 675-683, 2007.
14. Perloff D, Grim C, Flack J, et al: Human blood pressure determination by sphygmomanometry. Circulation 88: 2460-2470, 1993. (Pubitemid 23326128)
15. Yamada Y, Izawa H, Ichihara S, et al: Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347: 1916-1923, 2002.
16. Ten Have TR and Morabia A: Mixed effects models with bivariate and univariate association parameters for longitudinal bivariate binary response data. Biometrics 55: 85-93, 1999. (Pubitemid 29162008)
17. Hanley JA, Negassa A, Edwardes MD and Forrester JE: Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 157: 364-375, 2003. (Pubitemid 36196757)
18. Lalouel J-M and Rohrwasser A: Development of genetic hypotheses in essential hypertension. J Hum Genet 46: 299-306, 2001.
19. Groenendijk M, Cantor RM, De Bruin TW and Dallinga-Thie GM: The apoAI-CIII-AIV gene cluster. Atherosclerosis 157: 1-11, 2001.
20. Pennacchio LA, Olivier M, Hubacek JA, et al: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169-173, 2001. (Pubitemid 32952971)
21. Endo K, Yanagi H, Araki J, Hirano C, Yamakawa-Kobayashi K and Tomura S: Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet 111: 570-572, 2002. (Pubitemid 36075090)
22. Lai CQ, Tai ES, Tan CE, et al: The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 44: 2365-2373, 2003.
23. Aouizerat BE, Kulkarni M, Heilbron D, et al: Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res 44: 1167-1173, 2003. (Pubitemid 37279634)
24. Vu-Dac N, Gervois P, Jakel H, et al: Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators. J Biol Chem 278: 17982-17985, 2003. (Pubitemid 36799406)
25. Prieur X, Coste H and Rodriguez JC: The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-α and contains a novel farnesoid X-activated receptor response element. J Biol Chem 278: 25468-25480, 2003. (Pubitemid 36835298)
26. Spitaler M and Cantrell DA: Protein kinase C and beyond. Nat Immunol 5: 785-790, 2004.
27. Osada S, Mizuno K, Saido TC, et al: A phorbol ester receptor/protein kinase, nPKCη, a new member of the protein kinase C family predominantly expressed in lung and skin. J Biol Chem 265: 22434-22440, 1990. (Pubitemid 120014319)
28. Pham TN, Brown BL, Dobson PR and Richardson VJ: Protein kinase C-eta (PKCη) is required for the development of inducible nitric oxide synthase (iNOS) positive phenotype in human monocytic cells. Nitric Oxide 9: 123-134, 2003.
29. Fima E, Shtutman M, Libros P, et al: PKCη enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells. Oncogene 20: 6794-6804, 2001. (Pubitemid 33020608)
30. Matsumura M, Tanaka N, Kuroki T, Ichihashi M and Ohba M: The η isoform of protein kinase C inhibits UV-induced activation of caspase-3 in normal human keratinocytes. Biochem Biophys Res Commun 303: 350-356, 2003. (Pubitemid 36338248)
31. Aeder SE, Martin PM, Soh JW and Hussaini IM: PKC-η mediated glioblastoma cell proliferation through the Akt and mTOR signaling pathways. Oncogene 23: 9062-9069, 2004.
32. Kubo M, Hata J, Ninomiya T, et al: A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 39: 212-217, 2007. (Pubitemid 46184352)